Study: Fosamax helps build bone density in osteoporosis patients

08/11/2005 | MSNBC

Merck's Fosamax caused a 31% increase in the density of spine bones among women who had received parathyroid hormone shots to ward off the brittle bone disease, according to a study in the New England Journal of Medicine. The team found using Fosamax slowed the body's natural process of destroying old bones as the parathyroid hormone from NPS Pharmaceuticals increased bone growth.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA